News & Updates

Show Multimedia Only
BRAF, MEK Inhibitors linked to ocular adverse effects

BRAF, MEK Inhibitors linked to ocular adverse effects

07 Dec 2021

Treatment with BRAF and MEK inhibitors for metastatic melanoma is associated with several ocular adverse effects (OAE), a study has shown.

07 Dec 2021
Cholinesterase inhibitors show promise for treating gait disturbance in PD

Cholinesterase inhibitors show promise for treating gait disturbance in PD

07 Dec 2021

Treatment with cholinesterase inhibitors in patients with Parkinson’s disease (PD) leads to significant improvements in gait variability, with trending benefits for gait speed and fall prevention, according to the results of a meta-analysis.

07 Dec 2021